For example, amplification of the 19q12 locus has been reported in up to 15% of estrogen receptor (ER)‐negative breast cancers, typically resulting in amplification of CCNE1 (cyclin E1) (Adélaïde et al., 2007; Natrajan et al., 2012). Here, CCNE1 is linked to breast carcinoma.